Biomedicines Webinar | Proteomics and Its Applications in Cancer: Understanding the Molecular Landscape
the chair
11th Biomedicines Webinar
Proteomics and Its Applications in Cancer: Understanding the Molecular Landscape
Register for our webinar to learn about the powerful tool of proteomics that is emerging as a beacon of discovery in the intricate realm of cancer research. This dynamic field goes beyond diagnosis, influencing the development of targeted therapies and providing a more comprehensive understanding of the cancer landscape. Proteomics is also at the forefront of novel approaches to cancer treatment, from identifying unique protein signatures and their posttranslational modifications to investigating novel therapeutic targets.
Join us in exploring "Proteomics and its Application in Cancer," where we will present proteomics studies that hold keys to unlocking new possibilities in cancer detection, treatment, and personalized patient care.
Date: 14 December 2023
Time: 3:00 pm CET | 9:00 am EST | 10:00 pm CST Asia
Webinar ID: 885 2478 4335
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chair
Meet Our Speakers
Prof. Dr. Margrét Thorsteinsdóttir
Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland;
Dr. Margrét Thorsteinsdóttir is a Professor in Pharmaceutical Analytical Chemistry at the Faculty of Pharmaceutical Sciences, University of Iceland, and she is the founder and R&D Director of ArcticMass Ltd., Reykjavik, Iceland. Dr. Thorsteinsdóttir received her Ph.D. from Uppsala University, Sweden, in 1998. From 2000 to 2009, she was the managing director of Bioanalytical Laboratories at deCODE Genetics, Reykjavik, Iceland. She has extensive experience developing analytical methods for metabolite profiling and quantifying clinical biomarkers in various biofluids utilizing chemometrics, aiming to improve patient clinical management toward personalized patient care.
Her current research interest includes studies of lipid metabolism in cancer cells and profiling plasma-derived biomarkers for early detection of BRCA-related breast cancer. She is responsible for implementing clinical mass spectrometry to support diagnostics and therapeutic drug monitoring in collaboration with ArcticMass and the Landspitali University Hospital, Reykjavik, Iceland, focusing on multi-omics integrated processes for early detection of various diseases. She is one of the founders of Females in Mass Spectrometry (FeMS), a vice-leader of the working group clinical significance and applications of (epi)lipidomics in the pan-European network, EpiLipidNET, and vice-chair of the Nordic Metabolomics Society.
Prof. Dr. Maxim Berezovski
Molecular Diagnostics Laboratory, Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ontario, Canada;
Maxim Berezovski is a Professor of Bioanalytical Chemistry at the University of Ottawa in Canada. He received a Ph.D. from York University (Canada) in 2005 and did an NSERC postdoctoral fellowship at the University of Toronto (Canada). In 2009, he moved to the University of Ottawa (Canada) as an Assistant Professor. Before academia, he was the CEO of a pharmaceutical company for six years. Maxim currently leads the Laboratory of Molecular Diagnostics and supervises the Proteomic Mass Spectrometry Core Facility at uOttawa.
Maxim’s research focuses on bioanalytical chemistry, biological mass spectrometry, and molecular diagnostics. His lab develops analytical methods for studying biomolecular interactions with capillary electrophoresis and mass spectrometry, discovers protein biomarkers of extracellular vesicles, and makes aptamer-based sensors for tumor cells, viruses, and exosomes.
Prof. Dr. Costel C. Darie
Biochemistry & Proteomics Laboratories, Department of Chemistry & Biomolecular Science, Clarkson University, Potsdam, NY, USA;
With a rich academic background and a trajectory marked by academic achievements, Dr. Costel C. Darie has made substantial contributions to biochemistry and proteomics. Holding a BS and MS in Biochemistry from “Alexandru Ioan Cuza” University in Iasi, Romania, Dr. Darie pursued a Ph.D. in Biochemistry at “Albert Ludwigs” Universitaet Freiburg, Germany, followed by impactful postdoctoral studies at New York University Medical Center and Mount Sinai Medical Center in New York City, NY. In 2009, Dr. Darie embarked on an academic journey at Clarkson University, starting as an Assistant Professor and ascending to Full Professor. Over the years, Dr. Darie has mentored and guided more than 120 lab members, fostering a dynamic and collaborative research environment.
Dr. Darie's laboratory's research focuses on pioneering work in proteomics investigations of various bodily fluids, including sera, saliva, and breast milk. The overarching goal is the identification of biomarker signatures that serve as key indicators for disease detection, progression, or the presence of disorders. This groundbreaking research aligns with the pursuit of personalized patient care, striving for advancements in clinical management.
Sponsors and Partners
Organizer
In this section, you will find the recordings of this webinar to watch, re-watch and share with your colleagues!
"Proteomics and Its Applications in Cancer"
Edited by Dr. Cristian Munteanu and Dr. Brînduşa Alina Petre
Deadline for manuscript submissions: 31 March 2024